Palagtiw, Zillah Athalia C.

HRN: 24-58-16  Sex: Female

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
11/14/2024
CEFUROXIME 750MG (VIAL)
11/14/2024
11/21/2024
IV
450mg
Q8hours
ARTI
Waiting Final Action 

Indication:  Empiric    Type of Infection:  URTI    Compliance to guidelines: Compliant To Guidelines

Initial appropriateness: Yes   

Final appropriateness: Yes   

Overall appropriateness: Yes 

Intervention



Type of Intervention done:

                    

           


Acceptance: